NCT00238303View on ClinicalTrials.gov

Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

March 31, 2010

Conditions
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Tumor
Interventions
DRUG

vorinostat

Given orally

PROCEDURE

conventional surgery

Patients undergo surgery to remove tumor

Trial Locations (1)

55905

North Central Cancer Treatment Group, Rochester

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00238303 - Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter